AROUSAL RELATED TO EXCRETION OF NORADRENALINE METABOLITES AND CLINICAL ASPECTS OF UN-MEDICATED CHRONIC-SCHIZOPHRENIC PATIENTS

被引:15
作者
DEAKIN, JFW
BAKER, HF
FRITH, CD
JOSEPH, MH
JOHNSTONE, EC
机构
[1] Division of Psychiatry, Clinical Research Centre
关键词
D O I
10.1016/0022-3956(79)90007-4
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
1. 1. The interrelationship between the following psychophysiological, biochemical and clinical measures have been investigated in a group of unmedicated chronic schizophrenics; skin conductance level and orienting responses to tones; heart rate; excretion of vanillylmandelic acid (VMA), sulphate and total methoxyhydroxyphenylglycol (MHPG); clinical ratings of symptom severity. 2. 2. More severely ill subjects showed evidence of overarousal and had higher skin conductance levels and heart rates, and less habituation of skin conductance orienting responses to tones than the less severely ill. These measures were not related to ratings of anxiety. 3. 3. Physiological measures of peripheral autonomic function (skin conductance level and heart rate) were unexpectedly inversely related to VMA excretion, a noradrenaline metabolite putatively of peripheral origin, and to MHPG excretion. 4. 4. The central processes of habituation and symptom severity were more closely related to excretion of MHPG than VMA. This offers support for the suggestion that this noradrenaline metabolite more closely reflects brain noradrenaline turnover than VMA. The inverse relationship between MHPG excretion and measures of arousal suggests that brain noradrenergic transmission is not directly related to arousal levels in schizophrenia. 5. 5. Studies of these variables in control subjects will determine whether these findings are specific to schizophrenia. © 1979.
引用
收藏
页码:57 / 65
页数:9
相关论文
共 29 条
  • [11] PRESENCE OF FREE, SULFATE AND GLUCURONIDE CONJUGATED 3-METHOXY-4-HYDROXYPHENYLGLYCOL (MHPG) IN HUMAN-BRAIN, CEREBROSPINAL-FLUID AND PLASMA
    KAROUM, F
    MOYERSCHWING, J
    POTKIN, SG
    WYATT, RJ
    [J]. BRAIN RESEARCH, 1977, 125 (02) : 333 - 339
  • [12] KRAWIECKA M, 1976, ACTA PSYCHIAT SCAND
  • [13] PERIPHERAL AND CENTRAL ROLE OF CATECHOLAMINES IN MECHANISMS OF ANXIETY
    LADER, M
    [J]. INTERNATIONAL PHARMACOPSYCHIATRY, 1974, 9 (03): : 125 - 137
  • [14] LANG PETER J., 1965, J ABNORM PSYCHOL, V70, P77, DOI 10.1037/h0021942
  • [15] DIRECT MEASUREMENT OF SKIN CONDUCTANCE - PROPOSAL FOR STANDARDIZATION
    LYKKEN, DT
    VENABLES, PH
    [J]. PSYCHOPHYSIOLOGY, 1971, 8 (05) : 656 - +
  • [16] MAAS JW, 1968, J PHARMACOL EXP THER, V163, P147
  • [17] MAAS JW, 1971, J PHARMACOL EXP THER, V177, P600
  • [18] EXCRETION OF CATECHOLAMINE METABOLITES FOLLOWING INTRAVENTRICULAR INJECTION OF 6-HYDROXYDOPAMINE IN MACACA-SPECIOSA
    MAAS, JW
    DEKIRMENJIAN, H
    GARVER, D
    REDMOND, DE
    LANDIS, DH
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1973, 23 (02) : 121 - 130
  • [19] MAAS JW, PSYCHOPHARMAC COMMUN
  • [20] MATTINGLY D, 1964, LANCET, V2, P1046